Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 16, 581-584, August 1, 1956]
© 1956 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shils, M. E.
Right arrow Articles by Muller, M. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shils, M. E.
Right arrow Articles by Muller, M. V.

Quantitative Biochemical Differences between Tumor and Host as a Basis for Cancer Chemotherapy

III. Thiamine and Coenzyme A*

Maurice E. Shils, Ira M. Friedland, Albert S. Fine, Daniel M. Shapiro and Miss Vera Muller

( School of Public Health and Department of Surgery, College of Physicians and Surgeons, Columbia University, New York, N.Y.)

Coenzyme A and thiamine concentrations have been determined in the 755 mammary adenocarcinoma and in nine normal tissues of the C57 mouse. Co A was present in smaller amounts in skeletal muscle; tumor and lung each contained approximately twice as much, and the other seven normal tissues had appreciably more. Skeletal muscle had the lowest amount of thiamine, slightly less than the level in the tumor; all other normal tissue had significantly greater amounts. In comparing the distribution of these two factors with those of vitamin B6 and riboflavin, it is apparent that tumor falls consistently at the lower end of the scale in each instance, unlike the normal tissues. This fact furnishes support for the hypothesis that combinations of antimetabolites may injure neoplasms without seriously affecting normal tissues.

* This work was supported in part by Grant DRIR 244A(T) from the Damon Runyon Memorial Fund for Cancer Research and, in part, by Grants C-1783 and C-2446 from the National Cancer Institute, of the National Institutes of Health, Public Health Service.

Received 12/19/55.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1956 by the American Association for Cancer Research.